Abstract: Head injury is one of the most common causes of death worldwide & compound depressed skull fracture is an important cause of mortality & morbidity in this regard. Gradual urbanization and industrialization along with poor traffic control, use of over dated malfunctioning vehicles, poor and unplanned road traffic systems and overall lack of awareness of the people regarding traffic systems increase RTA (Road Traffic Accident) along with head injury. Besides this, assaults fall from height, sports injuries, birth trauma, etc are also important causes of head injury in our country. Health professionals are always facing these patients with a head injury in their everyday practice. Modern imaging facilities support early treatment and lead the outcome of compound depressed fractures of the skull towards zero mortality. But in developing countries like us due to lack of good health infrastructure & neurosurgical service along with the scarcity of neurosurgeons, communication problems, limited facilities and poverty of the people lead to a negative effect in the treatment of neurosurgical emergencies like a compound depressed fracture. This ultimately increases preventable mortality & morbidity of head-injured patients. The aim of the study will be to evaluate the ultimate outcome of primary bone fragment replacement in a compound depressed fracture which will be managed with our limited resources and to find out a plan of management of these patients to reduce mortality and morbidity. Further reading click here
Creatine kinase as a biomarker in muscle and heart health
1. **Creatine kinase (CK)** is an enzyme found in high concentrations in tissues with high energy demands—especially **skeletal muscle, heart muscle, and brain**—where it helps regenerate ATP from Creatine phosphate. 2. Because CK leaks into the blood when muscle cell membranes are damaged, its serum level serves as a general **marker of tissue injury** rather than damage to one specific organ. 3. CK exists as different **isoenzymes**—CK-MM (skeletal muscle), CK-MB (heart), and CK-BB (brain)—which help pinpoint the source of the damage. 4. **CK-MB** was long considered the classic biomarker for acute myocardial infarction, rising about 4–6 hours after injury, peaking near 24 hours, and returning to normal within 48–72 hours. 5. Its relatively **short half-life** makes CK-MB particularly valuable for detecting **re-infarction**, because levels fall quickly enough that a new rise is easy to recognize. 6. In skeletal muscle health, total CK is elevated in conditions such a...

0 Comments